Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika J Sims

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|May 22, 2012
Spirometry: an essential tool for screening, case-finding, and diagnosis of COPDErika J Sims, David Price
European Journal of Clinical Pharmacology|December 12, 2003
Concomitant occasional use of salbutamol influences bronchoprotective responsiveness afforded by formoterol in patients with the glycine-16 genotypeErika J Sims, Brian J Lipworth
Journal of Clinical Epidemiology|February 21, 2006
Delayed diagnosis of females with respiratory presentation of cystic fibrosis did not segregate with poorer clinical outcomeJonathan McCormick, Erika J Sims, Anil Mehta
Diabetes Care|June 29, 2005
Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetesErika J Sims, Michael W Green, Anil Mehta
British Journal of Clinical Pharmacology|July 10, 2003
Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotypeErika J Sims, Catherine M Jackson, Brian J Lipworth
The Journal of Pediatrics|September 27, 2005
Newborn screening for cystic fibrosis is associated with reduced treatment intensityErika J Sims, Jonathan McCormick, Gita Mehta, et al.
The Journal of Pediatrics|October 6, 2005
Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatmentErika J Sims, Jonathan McCormick, Gita Mehta, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 9, 2005
Asians with cystic fibrosis in the UK have worse disease outcomes than clinic matched white homozygous delta F508 controlsJonathan McCormick, Simon A Ogston, Erika J Sims, et al.
Allergy, Asthma & Immunology Research|October 4, 2011
Current control and future risk in asthma managementErika J Sims, David Price, John Haughney, et al.
British Journal of Clinical Pharmacology|December 21, 2004
Dose-response to salbutamol via a novel palm sized nebuliser (Aerodose Inhaler), conventional nebuliser (Pari LC Plus) and metered dose inhaler (Ventolin Evohaler) in moderate to severe asthmaticsBrian J Lipworth, Erika J Sims, Karla Taylor, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|May 22, 2012
Spirometry: an essential tool for screening, case-finding, and diagnosis of COPDErika J Sims, David Price
European Journal of Clinical Pharmacology|December 12, 2003
Concomitant occasional use of salbutamol influences bronchoprotective responsiveness afforded by formoterol in patients with the glycine-16 genotypeErika J Sims, Brian J Lipworth
Journal of Clinical Epidemiology|February 21, 2006
Delayed diagnosis of females with respiratory presentation of cystic fibrosis did not segregate with poorer clinical outcomeJonathan McCormick, Erika J Sims, Anil Mehta
Diabetes Care|June 29, 2005
Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetesErika J Sims, Michael W Green, Anil Mehta
British Journal of Clinical Pharmacology|July 10, 2003
Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotypeErika J Sims, Catherine M Jackson, Brian J Lipworth
The Journal of Pediatrics|September 27, 2005
Newborn screening for cystic fibrosis is associated with reduced treatment intensityErika J Sims, Jonathan McCormick, Gita Mehta, et al.
The Journal of Pediatrics|October 6, 2005
Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatmentErika J Sims, Jonathan McCormick, Gita Mehta, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 9, 2005
Asians with cystic fibrosis in the UK have worse disease outcomes than clinic matched white homozygous delta F508 controlsJonathan McCormick, Simon A Ogston, Erika J Sims, et al.
Allergy, Asthma & Immunology Research|October 4, 2011
Current control and future risk in asthma managementErika J Sims, David Price, John Haughney, et al.
British Journal of Clinical Pharmacology|December 21, 2004
Dose-response to salbutamol via a novel palm sized nebuliser (Aerodose Inhaler), conventional nebuliser (Pari LC Plus) and metered dose inhaler (Ventolin Evohaler) in moderate to severe asthmaticsBrian J Lipworth, Erika J Sims, Karla Taylor, et al.
Pageof 3